These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 36483446)

  • 41. Possibility of transmission of severe acute respiratory syndrome coronavirus 2 in a tertiary care hospital setting: A case study.
    Morioka S; Nakamura K; Iida S; Kutsuna S; Kinoshita N; Suzuki T; Suzuki T; Yamamoto K; Hayakawa K; Saito S; Ohmagari N
    Infect Prev Pract; 2020 Sep; 2(3):100079. PubMed ID: 34316564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comprehensive investigation of an in-hospital transmission cluster of a symptomatic SARS-CoV-2-positive physician among patients and healthcare workers in Germany.
    Wendt R; Nagel S; Nickel O; Wolf J; Kalbitz S; Kaiser T; Borte S; Lübbert C
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1209-1211. PubMed ID: 32489162
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of subclinical infection and transmission of severe acute respiratory syndrome (SARS) in a residential care home for the elderly.
    Heung LC; Li T; Mak SK; Chan WM
    Hong Kong Med J; 2006 Jun; 12(3):201-7. PubMed ID: 16760548
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Respiratory Aerosols Emitted by Patients With Coronavirus Disease 2019 (COVID-19) While Breathing, Talking, and Singing.
    Coleman KK; Tay DJW; Tan KS; Ong SWX; Than TS; Koh MH; Chin YQ; Nasir H; Mak TM; Chu JJH; Milton DK; Chow VTK; Tambyah PA; Chen M; Tham KW
    Clin Infect Dis; 2022 May; 74(10):1722-1728. PubMed ID: 34358292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparative overview of COVID-19, MERS and SARS: Review article.
    Liu J; Xie W; Wang Y; Xiong Y; Chen S; Han J; Wu Q
    Int J Surg; 2020 Sep; 81():1-8. PubMed ID: 32730205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vaccination Setting of Patients with Autoimmune Diseases in Times of Severe Acute Respiratory Syndrome Coronavirus Type 2 Pandemic Using the Example of Multiple Sclerosis Patients: A Longitudinal Multicenter Study.
    Heidler F; Baldt J; Frahm N; Langhorst SE; Mashhadiakbar P; Streckenbach B; Zettl UK; Richter J
    Eur Neurol; 2022; 85(2):104-111. PubMed ID: 34743082
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maintaining an Adult Hematology/Oncology Service at a Tertiary Care Center during the SARS-CoV-2 Pandemic: An Eight-Week-Experience with a Newly Implemented Procedural Plan.
    Hemmati PG; Fischer D; Breywisch F; Wohlfarth S; Kramer M; Paland M; Tometten L; Badakhshi H; Ripberger G; Maschmeyer G
    Oncol Res Treat; 2021; 44(6):354-359. PubMed ID: 33940575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Corrigendum: Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus.
    Santos IKFM; Costa CHN
    Front Immunol; 2020; 11():615628. PubMed ID: 33224154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Letter to the editor: Wide indication for SARS-CoV-2-testing allowed identification of international risk areas during the early phase of the COVID-19 pandemic in Germany.
    Rexroth U; Hamouda O; Hanefeld J; Ruehe B; Wieler LH; Schaade L
    Euro Surveill; 2020 Jun; 25(23):. PubMed ID: 32553063
    [No Abstract]   [Full Text] [Related]  

  • 50. Causes of death and post-mortem testing for SARS-CoV-2 in a tertiary hospital during the COVID-19 pandemic in Ghana.
    Asumanu E; Attoh S; Servor RX; Laryea C; McAddy M; Hobenu F; Factchu R; Agyemang-Bediako K; Nyarko EO; Nyarko GK; Moroti MK; Edusei L
    Afr J Lab Med; 2022; 11(1):1766. PubMed ID: 36483325
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SARS-CoV-2 Cluster in Nursery, Poland.
    Okarska-Napierała M; Mańdziuk J; Kuchar E
    Emerg Infect Dis; 2021 Jan; 27(1):317-9. PubMed ID: 33035153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Environmental surface and air contamination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patient rooms by disease severity.
    Nakamura K; Morioka S; Kutsuna S; Iida S; Suzuki T; Kinoshita N; Suzuki T; Sugiki Y; Okuhama A; Kanda K; Wakimoto Y; Ujiie M; Yamamoto K; Ishikane M; Moriyama Y; Ota M; Nakamoto T; Ide S; Nomoto H; Akiyama Y; Miyazato Y; Hayakawa K; Saito S; Ohmagari N
    Infect Prev Pract; 2020 Dec; 2(4):100098. PubMed ID: 34316568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insertion-and-Deletion Mutations between the Genomes of SARS-CoV, SARS-CoV-2, and Bat Coronavirus RaTG13.
    Akaishi T
    Microbiol Spectr; 2022 Jun; 10(3):e0071622. PubMed ID: 35658573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus.
    Patrick DM; Petric M; Skowronski DM; Guasparini R; Booth TF; Krajden M; McGeer P; Bastien N; Gustafson L; Dubord J; Macdonald D; David ST; Srour LF; Parker R; Andonov A; Isaac-Renton J; Loewen N; McNabb G; McNabb A; Goh SH; Henwick S; Astell C; Guo JP; Drebot M; Tellier R; Plummer F; Brunham RC
    Can J Infect Dis Med Microbiol; 2006 Nov; 17(6):330-6. PubMed ID: 18382647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anesthetic Complications Associated With Severe Acute Respiratory Syndrome Coronavirus 2 in Pediatric Patients.
    Saynhalath R; Alex G; Efune PN; Szmuk P; Zhu H; Sanford EL
    Anesth Analg; 2021 Aug; 133(2):483-490. PubMed ID: 33886516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
    Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
    J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Poor Antibody Response to BioNTech/Pfizer Coronavirus Disease 2019 Vaccination in Severe Acute Respiratory Syndrome Coronavirus 2-Naive Residents of Nursing Homes.
    Pannus P; Neven KY; De Craeye S; Heyndrickx L; Vande Kerckhove S; Georges D; Michiels J; Francotte A; Van Den Bulcke M; Zrein M; Van Gucht S; Schmickler MN; Verbrugghe M; Matagne A; Thomas I; Dierick K; Weiner JA; Ackerman ME; Goriely S; Goossens ME; Ariën KK; Desombere I; Marchant A
    Clin Infect Dis; 2022 Aug; 75(1):e695-e704. PubMed ID: 34864935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coronavirus Disease 2019 (COVID-19) Outbreak Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) P.1 Lineage in a Long-Term Care Home After Implementation of a Vaccination Program-Ontario, Canada, April-May 2021.
    Williams C; Al-Bargash D; Macalintal C; Stuart R; Seth A; Latham J; Gitterman L; Fedsin S; Godoy M; Kozak R; Guthrie JL; Wood H; McGeer A; Hota S; Rea E
    Clin Infect Dis; 2022 Mar; 74(6):1085-1088. PubMed ID: 34240103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.